Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hon

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 9, 2008
Using the National Institutes of Health Stroke Scale (NIHSS) to predict the mortality and outcome of patients with intracerebral haemorrhageC M Cheung, T H Tsoi, Sonny F K Hon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancerVera Hirsh, Isamu Okamoto, Jeremy K Hon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 8, 2010
Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videosR T F Cheung, P D Lyden, T H Tsoi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trialJ D Hainsworth, W J Urba, J K Hon, et al.
Circulation|September 25, 2001
Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operationG S Carr-White, P J Kilner, J K Hon, et al.
The Medical Journal of Malaysia|April 15, 2011
The National Medical Research Register--a vital link between current and future researchT O Lim, S I Asmaliza, P P Goh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2013
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancerM A Socinski, I Okamoto, J K Hon, et al.
American Heart Journal|November 22, 2001
Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failureM K Al-Obaidi, J K Hon, P J Stubbs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|October 9, 2008
Using the National Institutes of Health Stroke Scale (NIHSS) to predict the mortality and outcome of patients with intracerebral haemorrhageC M Cheung, T H Tsoi, Sonny F K Hon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancerVera Hirsh, Isamu Okamoto, Jeremy K Hon, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 8, 2010
Production and validation of Putonghua- and Cantonese-Chinese language National Institutes of Health Stroke Scale training and certification videosR T F Cheung, P D Lyden, T H Tsoi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trialJ D Hainsworth, W J Urba, J K Hon, et al.
Circulation|September 25, 2001
Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operationG S Carr-White, P J Kilner, J K Hon, et al.
The Medical Journal of Malaysia|April 15, 2011
The National Medical Research Register--a vital link between current and future researchT O Lim, S I Asmaliza, P P Goh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2013
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancerM A Socinski, I Okamoto, J K Hon, et al.
American Heart Journal|November 22, 2001
Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failureM K Al-Obaidi, J K Hon, P J Stubbs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.
Pageof 8